USPTO trademark

ACCESS DAXXIFY

RegisteredUSPTOWord markClass 35

"ACCESS DAXXIFY" is a word mark owned by Revance Therapeutics, Inc., filed at the USPTO on November 6, 2023. It is registered and covers class 35 (Advertising and Business).

View Revance Therapeutics, Inc. portfolio Get this data via the API

Data current as of August 5, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since August 5, 2025
Filed: November 6, 2023
Registered: August 5, 2025
Expires: Not recorded
Application no.: 98256350
Registration no.: 7883785
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns ACCESS DAXXIFY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Revance Therapeutics, Inc.

Newark, United States

148 trademarks in the portfolioView company

Representative

Jennifer Waitman

Kilpatrick Townsend & Stockton LLP

Goods and services

What the mark covers

The products and services ACCESS DAXXIFY is filed for, grouped by Nice class.

35Class 35 · Advertising and Business
Business administration of patient reimbursement programs; Business management of reimbursement programs for others

History

What has happened so far

Steps recorded by the USPTO, newest first.

August 5, 2025Notice of registration confirmation emailed
August 5, 2025Registered-principal register
July 30, 2025Teas change of correspondence received
July 30, 2025Attorney/dom.rep.revoked and/or appointed
July 30, 2025Teas revoke/app/change addr of atty/dom rep received
July 16, 2025Notice of acceptance of statement of use e-mailed
July 14, 2025Allowed principal register - sou accepted
June 13, 2025Statement of use processing complete
June 12, 2025Case assigned to intent to use paralegal
April 2, 2025Assigned to examiner

10 earlier steps on the official record.

FAQ

About ACCESS DAXXIFY

Who owns the trademark "ACCESS DAXXIFY"?

The USPTO trademark "ACCESS DAXXIFY" (application 98256350) is owned by Revance Therapeutics, Inc.

What is the status of "ACCESS DAXXIFY"?

Its status at the USPTO is: registered.

When was "ACCESS DAXXIFY" registered?

It was registered on August 5, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ACCESS DAXXIFY and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2c44-90c9-736c-af7a-8f5167eb3efe
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2c44-90c9-736c-af7a-8f5167eb3efe",
  "object": "trademark",
  "mark_text": "ACCESS DAXXIFY",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98256350",
  "filing_date": "2023-11-06",
  "nice_classes": [
    35
  ],
  "owners": [
    {
      "name": "Revance Therapeutics, Inc.",
      "entity_id": "ent_019ebbb2-c9af-75c8-a4ea-bcf8c6c82424"
    }
  ]
}